Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetes.
Pharmacokinetics, safety, tolerability and efficacy of the cotadutide, a glucagon-like peptide-1 and glucagon receptor dual agonist in phase 1 and 2 of trials in overweight or obese participants of Asian descent with or without type 2 diabetes.